Report overview
This report contains market size and forecasts of Bile Duct Cancer Drug in global, including the following market information:
Global Bile Duct Cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bile Duct Cancer Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Bile Duct Cancer Drug companies in 2021 (%)
The global Bile Duct Cancer Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cabozantinib S-malate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bile Duct Cancer Drug include Ariad Pharmaceuticals, Inc., ArQule, Inc., Array BioPharma Inc., Arrien Pharmaceuticals, LLC, Aslan Pharmaceuticals Pte. Ltd., Bavarian Nordic A/S, Bayer AG, Blueprint Medicines Corporation and Boehringer Ingelheim GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bile Duct Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bile Duct Cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Bile Duct Cancer Drug Market Segment Percentages, by Type, 2021 (%)
Cabozantinib S-malate
Elpamotide
Exatecan Mesylate
LY-2801653
NUC-1031
Others
Global Bile Duct Cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Bile Duct Cancer Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Bile Duct Cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Bile Duct Cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bile Duct Cancer Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bile Duct Cancer Drug revenues share in global market, 2021 (%)
Key companies Bile Duct Cancer Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Bile Duct Cancer Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ariad Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Arrien Pharmaceuticals, LLC
Aslan Pharmaceuticals Pte. Ltd.
Bavarian Nordic A/S
Bayer AG
Blueprint Medicines Corporation
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
CellAct Pharma GmbH
Cellceutix Corporation
Cellular Biomedicine Group, Inc.
Concordia Healthcare Corp.
